Lauren Merendino
Director/Board Member at ESSA PHARMA INC.
Net worth: - $ as of 2024-05-30
Profile
Lauren Merendino currently works at ESSA Pharma, Inc., as Independent Non-Executive Director from 2023 and Day One Biopharmaceuticals, Inc., as Chief Commercial Officer from 2023.
Ms. Merendino also formerly worked at Genentech, Inc., as Vice President-Neurological Rare Diseases from 2018 to 2021, Myovant Sciences, Inc., as Chief Commercial Officer, and Myovant Sciences Ltd., as Chief Commercial Officer.
Ms. Merendino received her Masters Business Admin degree from New York University and undergraduate degree from The Pennsylvania State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ESSA PHARMA INC
-.--% | 2024-03-24 | 0 ( -.--% ) | - $ | 2024-05-30 |
Lauren Merendino active positions
Companies | Position | Start |
---|---|---|
DAY ONE BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-04-30 |
ESSA PHARMA INC. | Director/Board Member | 2023-06-05 |
Former positions of Lauren Merendino
Companies | Position | End |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2021-03-31 |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
MYOVANT SCIENCES LTD. | Corporate Officer/Principal | - |
Training of Lauren Merendino
The Pennsylvania State University | Undergraduate Degree |
New York University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
ESSA PHARMA INC. | Health Technology |
Private companies | 3 |
---|---|
Myovant Sciences Ltd.
Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Lauren Merendino